Li Ka Shing Applied Virology Institute (AVI)

lika-shing_2018_-37-3.jpg

The Li Ka Shing Applied Virology Institute (LKSAVI or AVI) is the translation and commercialization hub of the Li Ka Shing Institute of Virology.


AVI Featured News

LKSIoV Members, Dr. Michael Good and Dr. Michael Hawkes, along with LKSAVI and an international team, begin human clinical trials for a Strep A vaccine

Today, a team of international scientists from Griffith University and the University of Alberta started human clinical trials for a Strep A vaccine that they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.


About AVI

Our mission is to help transition nascent technologies in the life sciences sector into clinical relevance, providing funding, technology development support and commercialization guidance. 

Current Projects

We manage and explore various commercialization projects aimed at improving human health. Our active broad portfolio of programs include vaccines, therapeutics, diagnostics, and the development of research tools for each project.

Research Articles

Our researchers actively publish their findings in reputable, peer-reviewed journals.

Support and Give to AVI

We count on you to make a difference. We require your support to ensure the continuance of the scientific advancements currently being made at the LKSAVI.